Perry Evans
Impact in
- Hematology top 10%
- Blood groups and transfusion
- Molecular Biology top 10%
- Melanoma and MAPK Pathways
- Genomics and Chromatin Dynamics
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Redox biology and oxidative stress
Papers in
-
- Genomics and Phylogenetic Studies 4
- Genomics and Chromatin Dynamics 3
- CRISPR and Genetic Engineering 3
- Protein Degradation and Inhibitors 2
- Genetics 8
- Genomics and Rare Diseases 5
- Genomic variations and chromosomal abnormalities 4
- Co-authors
- Michael Krauthammer (6 shared papers)Harry Ischiropoulos (4 shared papers)Lyle Ungar (4 shared papers)Aydın Tözeren (3 shared papers)Cheryl A. Keller (4 shared papers)Belinda Giardine (4 shared papers)Gerd A. Blobel (4 shared papers)Ross C. Hardison (4 shared papers)
- Journals
- BMC Medical Genomics (2 papers)Blood (2 papers)PLoS ONE (2 papers)Nature Communications (1 paper)Transfusion (1 paper)
- Partner nations
- United StatesUnited Arab EmiratesSwitzerland
In The Last Decade
Perry Evans
27 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Hematology 127
- Molecular Biology 782
- Oncology 206
- Biochemistry 57
- Virology 32
Countries citing papers authored by Perry Evans
This map shows the geographic impact of Perry Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Evans more than expected).
Fields of papers citing papers by Perry Evans
This network shows the impact of papers produced by Perry Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Evans. The network helps show where Perry Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Perry Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 286 | |
| 2 | 2015 | 113 | |
| 3 | 2015 | 109 | |
| 4 | 2017 | 98 | |
| 5 | 2018 | 89 | |
| 6 | 2015 | 86 | |
| 7 | 2016 | 82 | |
| 8 | 2009 | 76 | |
| 9 | 2013 | 41 | |
| 10 | 2018 | 35 | |
| 11 | 2018 | 33 | |
| 12 | Exploring the use of social media to measure journal article impact. | 2011 | 32 |
| 13 | 2018 | 18 | |
| 14 | 2019 | 16 | |
| 15 | 2009 | 12 | |
| 16 | 2018 | 11 | |
| 17 | 2023 | 10 | |
| 18 | 2019 | 10 | |
| 19 | 2010 | 8 | |
| 20 | 2013 | 8 |
About Perry Evans
Perry Evans is a scholar working on Molecular Biology, Genetics, Physiology, Cancer Research and Neurology, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Genomics and Rare Diseases (5 papers), Cancer Genomics and Diagnostics (4 papers), Genomic variations and chromosomal abnormalities (4 papers), Genomics and Phylogenetic Studies (4 papers), Genomics and Chromatin Dynamics (3 papers), CRISPR and Genetic Engineering (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Hematology (127 citations), Molecular Biology (782 citations), Oncology (206 citations), Biochemistry (57 citations) and Virology (32 citations). Perry Evans has collaborated with scholars based in United States, United Arab Emirates and Switzerland. Frequent co-authors include Michael Krauthammer, Harry Ischiropoulos, Lyle Ungar, Aydın Tözeren, Cheryl A. Keller, Belinda Giardine, Gerd A. Blobel, Ross C. Hardison, William Dampier and Aaron J. Stonestrom. Their work appears in journals such as BMC Medical Genomics, Blood, PLoS ONE, Nature Communications and Transfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.